Screening for Mild Cognitive Impairment Using a Machine Learning Classifier and the Remote Speech Biomarker for Cognition: Evidence from Two Clinically Relevant Cohorts

BACKGROUND: Modern prodromal Alzheimer’s disease (AD) clinical trials might extend outreach to a general population, causing high screen-out rates and thereby increasing study time and costs. Thus, screening tools that cost-effectively detect mild cognitive impairment (MCI) at scale are needed. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Simona, Mallick, Elisa, Schwed, Louisa, König, Alexandra, Zhao, Jian, Linz, Nicklas, Bodin, Timothy Hadarsson, Skoog, Johan, Possemis, Nina, ter Huurne, Daphne, Zettergren, Anna, Kern, Silke, Sacuiu, Simona, Ramakers, Inez, Skoog, Ingmar, Tröger, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912722/
https://www.ncbi.nlm.nih.gov/pubmed/36565116
http://dx.doi.org/10.3233/JAD-220762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912722/
https://www.ncbi.nlm.nih.gov/pubmed/36565116
http://dx.doi.org/10.3233/JAD-220762

Ejemplares similares